100% accuracy
of data
of data
24/7 scientific
support
support
0% tolerance in
quality of product
quality of product
Stock Locations
- New Jersey, USA
- Czech Republic, EU
- Mumbai, India
* Stock subject to availability.
Documentation
Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.
139272-66-5Aceclofenac EP Impurity D
● In Stock
| Catalogue No.: | VL284002 |
|---|---|
| CAS No.: | 139272-66-5 |
| Mol. Formula: | C17H15Cl2NO4 |
| Mol. Weight: | 368.21 g/mol |
Additional information on CAS 139272-66-5
Parent drug
AceclofenacIUPAC Name
Methyl [[[2-[(2, 6-dichlorophenyl)amino]phenyl] acetyl]oxy]acetatePharmacopoeial Synonyms
Aceclofenac Methyl EsterOther Synonyms
Aceclofenac Impurity D; Methyl Aceclofenac; 2-Methoxy-2-oxoethyl 2-(2-(2,6-dichlorophenylamino)-phenyl)acetate; (2-methoxy-2-oxoethyl) 2-[2-(2,6-dichloroanilino)phenyl]acetate Benzeneacetic acid ; 2-[(2,6-dichlorophenyl)amino]-, 2-methoxy-2-oxoethyl esterDescription
Aceclofenac EP Impurity D (CAS No: 139272-66-5) or Methyl [[[2-[(2,6-dichlorophenyl)amino]phenyl] acetyl]oxy]acetate is a degradation product of Aceclofenac that is a phenylacetic acid derivative with anti-inflammatory and analgesic characteristics comparable to those of diclofenac.References
Karbhari, PradnyaA, et al. “RP-LC Gradient Elution Method for Simultaneous Determination of Thiocolchicoside, Aceclofenac and Related Impurities in Tablet Formulation.” Journal of Pharmacy and Bioallied Sciences, vol. 6, no. 4, 2014, p. 246, https://doi.org/10.4103/0975-7406.142955. Brogden, Rex N., and Lynda R. Wiseman. “Aceclofenac.” Drugs, vol. 52, no. 1, July 1996, pp. 113–24, https://doi.org/10.2165/00003495-199652010-00008. ?Request a Quote
"*" indicates required fields
Other products related to Aceclofenac impurities
Impurity structure
Parent Drug Name
CAS No.
Name of Impurity
Catalog No.
Aceclofenac
CAS No. 89796-99-6
Cat No. VE0010527
